BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)
BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)
This is an updated guideline for the diagnosis and management of allergic and non-allergic rhinitis, first published in 2007. It was produced by the Standards of Care Committee of the British Society of Allergy and Clinical Immunology, using accredited methods. Allergic rhinitis is common and affects 10-15% of children and 26% of adults in the UK, it affects quality of life, school and work attendance, and is a risk factor for development of asthma. Allergic rhinitis is diagnosed by history and examination, supported by specific allergy tests. Topical nasal corticosteroids are the treatment of choice for moderate to severe disease. Combination therapy with intranasal corticosteroid plus intranasal antihistamine is more effective than either alone and provides second line treatment for those with rhinitis poorly controlled on monotherapy. Immunotherapy is highly effective when the specific allergen is the responsible driver for the symptoms. Treatment of rhinitis is associated with benefits for asthma. Non-allergic rhinitis also is a risk factor for the development of asthma and may be eosinophilic and steroid-responsive or neurogenic and non- inflammatory. Non-allergic rhinitis may be a presenting complaint for systemic disorders such as granulomatous or eosinophilic polyangiitis, and sarcoidoisis. Infective rhinitis can be caused by viruses, and less commonly by bacteria, fungi and protozoa.
856-889
Scadding, G K
134b8fab-3444-435d-9efb-1a8560e020ee
Kariyawasam, H H
5d3ac27a-9639-44c2-8fba-2088735e7c4f
Scadding, G
cbf15f6d-2c0f-40b6-b758-9be7306fa43b
Mirakian, R
64e70818-31bf-4f2b-9f38-3e2ecbdbcc1b
Dixon, T
c697f109-bc2f-4c5a-892a-8e30fbc978d8
Durham, S R
99964123-7d76-411f-94d6-fbddfb1840c8
Farooque, S
bee79769-f69c-4cd6-a956-347943b01b68
Leech, S
1d2a065a-37c8-4ad6-bfbb-1c431a8e9e42
Nasser, S M
3c932f67-dfa3-401b-b3a5-313399901643
Rotiroti, G
4ac097e6-01cf-449a-a493-d41d8bfb2e0f
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
July 2017
Scadding, G K
134b8fab-3444-435d-9efb-1a8560e020ee
Kariyawasam, H H
5d3ac27a-9639-44c2-8fba-2088735e7c4f
Scadding, G
cbf15f6d-2c0f-40b6-b758-9be7306fa43b
Mirakian, R
64e70818-31bf-4f2b-9f38-3e2ecbdbcc1b
Dixon, T
c697f109-bc2f-4c5a-892a-8e30fbc978d8
Durham, S R
99964123-7d76-411f-94d6-fbddfb1840c8
Farooque, S
bee79769-f69c-4cd6-a956-347943b01b68
Leech, S
1d2a065a-37c8-4ad6-bfbb-1c431a8e9e42
Nasser, S M
3c932f67-dfa3-401b-b3a5-313399901643
Rotiroti, G
4ac097e6-01cf-449a-a493-d41d8bfb2e0f
Roberts, Graham
ea00db4e-84e7-4b39-8273-9b71dbd7e2f3
Scadding, G K, Kariyawasam, H H, Scadding, G, Mirakian, R, Dixon, T, Durham, S R, Farooque, S, Leech, S, Nasser, S M, Rotiroti, G and Roberts, Graham
(2017)
BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007).
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 47 (7), .
(doi:10.1111/cea.12953).
Abstract
This is an updated guideline for the diagnosis and management of allergic and non-allergic rhinitis, first published in 2007. It was produced by the Standards of Care Committee of the British Society of Allergy and Clinical Immunology, using accredited methods. Allergic rhinitis is common and affects 10-15% of children and 26% of adults in the UK, it affects quality of life, school and work attendance, and is a risk factor for development of asthma. Allergic rhinitis is diagnosed by history and examination, supported by specific allergy tests. Topical nasal corticosteroids are the treatment of choice for moderate to severe disease. Combination therapy with intranasal corticosteroid plus intranasal antihistamine is more effective than either alone and provides second line treatment for those with rhinitis poorly controlled on monotherapy. Immunotherapy is highly effective when the specific allergen is the responsible driver for the symptoms. Treatment of rhinitis is associated with benefits for asthma. Non-allergic rhinitis also is a risk factor for the development of asthma and may be eosinophilic and steroid-responsive or neurogenic and non- inflammatory. Non-allergic rhinitis may be a presenting complaint for systemic disorders such as granulomatous or eosinophilic polyangiitis, and sarcoidoisis. Infective rhinitis can be caused by viruses, and less commonly by bacteria, fungi and protozoa.
This record has no associated files available for download.
More information
Published date: July 2017
Identifiers
Local EPrints ID: 429707
URI: http://eprints.soton.ac.uk/id/eprint/429707
ISSN: 0954-7894
PURE UUID: 383d272e-6518-4b11-8ab6-1d494b25e11b
Catalogue record
Date deposited: 04 Apr 2019 16:30
Last modified: 16 Mar 2024 03:44
Export record
Altmetrics
Contributors
Author:
G K Scadding
Author:
H H Kariyawasam
Author:
G Scadding
Author:
R Mirakian
Author:
T Dixon
Author:
S R Durham
Author:
S Farooque
Author:
S Leech
Author:
S M Nasser
Author:
G Rotiroti
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics